胰高血糖素试验在儿童期起病生长激素缺乏症年轻成人过渡期的准确性
研究纳入97例儿童期起病生长激素缺乏症患者,在中位年龄17.39岁时行胰岛素耐量试验、胰高血糖素试验和胰岛素样生长因子-1检测,以评估胰高血糖素试验相较于胰岛素耐量试验诊断生长激素缺乏症的准确性;结论认为胰高血糖素试验生长激素峰值<5.8 μg/L是年轻成人儿童期起病生长激素缺乏症且验前概率高的准确诊断切点。
要点
- 胰高血糖素试验与胰岛素耐量试验的生长激素峰值测量一致性高。
- 胰高血糖素试验生长激素峰值7.3 μg/L可正确分类91.8%的整个队列。
- 胰高血糖素试验生长激素峰值5.8 μg/L可正确分类91.4%的中度器质性生长激素缺乏症患者。
核心结论
- 胰高血糖素试验生长激素峰值<5.8 μg/L是年轻成人儿童期起病生长激素缺乏症且永久性生长激素缺乏症验前概率高的准确诊断切点。
研究设计与样本
- 97例儿童期起病生长激素缺乏症患者(中位年龄17.39岁)接受胰岛素耐量试验、胰高血糖素试验和胰岛素样生长因子-1检测;44例为特发性(孤立性生长激素缺乏症),35例为中度器质性生长激素缺乏症(0-2种激素缺乏),18例为重度器质性生长激素缺乏症(≥3种激素缺乏)。
主要发现
- Bland-Altman分析显示胰岛素耐量试验与胰高血糖素试验的生长激素峰值测量一致性高。
- 受试者工作特征分析确定胰高血糖素试验生长激素峰值7.3 μg/L为最佳切点(95%CI 4.15-8.91;敏感度95.7%,特异度88.2%,阳性预测值88.0%,阴性预测值95.7%),可正确分类整个队列的91.8%。
- 胰高血糖素试验生长激素峰值5.8 μg/L为最佳切点,可正确分类中度器质性生长激素缺乏症患者的91.4%(95%CI 3.16-7.39;敏感度96.0%,特异度80.0%,阳性预测值92.3%,阴性预测值88.9%)。
- ≥3种激素缺乏的患者胰岛素耐量试验生长激素峰值<5 μg/L、胰高血糖素试验生长激素峰值<5.8 μg/L。
- 胰岛素样生长因子-1最佳切点为-1.4 SD评分(95%CI -1.94至0.77;敏感度75%,特异度94%,阳性预测值91.7%,阴性预测值81.0%),可正确分类研究人群的85.1%。
关键数值与推荐
- 2019年美国临床内分泌医师协会指南建议过渡期永久性生长激素缺乏症诊断中胰高血糖素试验生长激素峰值切点为≤3和≤1 μg/L。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The 2019 American Association of Clinical Endocrinologists guidelines suggested peak GH-cutoffs to glucagon test (GST) of ≤3 and ≤1 µg/L in the diagnosis of permanent GH deficiency (GHD) during the transition phase. OBJECTIVE: The aim of the study was to evaluate the accuracy of GST compared to insulin tolerance test (ITT) in the definition of GHD at adult height achievement. PATIENTS AND METHODS: Ninety-seven subjects with childhood-onset GHD (median age, 17.39 years) underwent ITT, GST, and IGF-1 testing; 44 subjects were idiopathic (isolated GHD), 35 moderate organic GHD (0-2 hormone deficiencies) and 18 severe organic GHD (≥3 hormone deficiencies). RESULTS: Bland and Altman analysis showed a high consistency of GH peak measures after ITT and GST. Receiver operating characteristic analysis identified 7.3 μg/L as the optimal GH peak cutoff to GST [95% confidence interval (CI) 4.15-8.91; sensitivity 95.7%, specificity 88.2%, positive predictive value (PPV) 88.0%, negative predictive value (NPV) 95.7%] able to correctly classify 91.8% of the entire cohort while 5.8 μg/L was the best GH peak cutoff able to correctly classify 91.4% of moderate organic GHD patients (95% CI 3.16-7.39; sensitivity 96.0%, specificity 80.0%, PPV 92.3%, NPV 88.9%). Patients with ≥3 hormone deficiencies showed a GH peak <5 μg/L at ITT and <5.8 μg/L at GST but 1. The optimal cutoff for IGF-1 was -1.4 SD score (95% CI -1.94 to 0.77; sensitivity 75%, specificity 94%, PPV 91.7%, NPV 81.0%) that correctly classified 85.1% of the study population. CONCLUSION: A GH peak to GST <5.8 μg/L represents an accurate diagnostic cutoff for young adults with childhood-onset GHD and high pretest probability of permanent GHD.
引用
- Fava D, Guglielmi D, Pepino C, et al. Accuracy of Glucagon Testing Across Transition in Young Adults With Childhood-Onset GH Deficiency. J Clin Endocrinol Metab. 2024. PMID: 38913686. doi:10.1210/clinem/dgae408
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。